Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (23)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Bayer, T.
Right arrow Articles by Dekant, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bayer, T.
Right arrow Articles by Dekant, W.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Toxicological Sciences 62, 205-211 (2001)
Copyright © 2001 by the Society of Toxicology

BIOTRANSFORMATION AND TOXICOKINETICS

Disposition and Biotransformation of the Estrogenic Isoflavone Daidzein in Rats

Tanja Bayer, Thomas Colnot and Wolfgang Dekant,1

Institut für Toxikologie, Universität Würzburg, Versbacher Str. 9, 97078 Würzburg, Germany

Daidzein is an estrogenic isoflavone present in many plants and therefore consumed in relatively high doses by humans. Daidzein has a low affinity for the estrogen receptor (3 orders of magnitude lower than estradiol) and has been demonstrated to have estrogenic effects in rodents after administration of high doses. We have studied the disposition and biotransformation of daidzein in rats fed a diet low in isoflavone content. Four male and four female Fischer 344 rats were orally administered 100 mg/kg daidzein; excreted urine and feces were collected for 96 h and unchanged daidzein as well as formed metabolites were quantified by HPLC. In urine of male rats, daidzein, daidzein-glucuronide, and daidzein-sulfate were excreted; in females, only unchanged daidzein and daidzein-glucuronide were present. Total urinary excretion of daidzein accounted for < 10% of dose in both males and females. The major pathway of daidzein elimination was excretion of unchanged daidzein with feces. Reductive daidzein-metabolites likely formed by intestinal microflora (equol, O-desmethylangolensin) were excreted with feces in small amounts (< 5% of dose). Excretion of daidzein and metabolites with urine and feces was rapid with elimination half-lives of less than 12 h; daidzein concentrations in urine and feces were below the limit of detection 36 h after daidzein administration. The results suggest that daidzein is only poorly absorbed from the gastrointestinal tract in rodents. Absorbed daidzein is rapidly eliminated both unchanged and as conjugates with urine. The inefficient absorption of daidzein from the gastrointestinal tract and the rapid excretion may explain the weak estrogenicity of daidzein seen in vivo in rodents when compared to other estrogenic chemicals with comparatively low affinity to the estrogen receptor.

Key Words: daidzein; estrogen; isoflavone; disposition.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Appl. Environ. Microbiol.Home page
A. Matthies, T. Clavel, M. Gutschow, W. Engst, D. Haller, M. Blaut, and A. Braune
Conversion of Daidzein and Genistein by an Anaerobic Bacterium Newly Isolated from the Mouse Intestine
Appl. Envir. Microbiol., August 1, 2008; 74(15): 4847 - 4852.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
J. Enokizono, H. Kusuhara, and Y. Sugiyama
Effect of Breast Cancer Resistance Protein (Bcrp/Abcg2) on the Disposition of Phytoestrogens
Mol. Pharmacol., October 1, 2007; 72(4): 967 - 975.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
Y. H. Ju, J. Fultz, K. F. Allred, D. R. Doerge, and W. G. Helferich
Effects of dietary daidzein and its metabolite, equol, at physiological concentrations on the growth of estrogen-dependent human breast cancer (MCF-7) tumors implanted in ovariectomized athymic mice
Carcinogenesis, April 1, 2006; 27(4): 856 - 863.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
E. Pfeiffer, C. R. Treiling, S. I. Hoehle, and M. Metzler
Isoflavones modulate the glucuronidation of estradiol in human liver microsomes
Carcinogenesis, December 1, 2005; 26(12): 2172 - 2178.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
W. Volkel, N. Bittner, and W. Dekant
QUANTITATION OF BISPHENOL A AND BISPHENOL A GLUCURONIDE IN BIOLOGICAL SAMPLES BY HIGH PERFORMANCE LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY
Drug Metab. Dispos., November 1, 2005; 33(11): 1748 - 1757.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
P. Totta, F. Acconcia, F. Virgili, A. Cassidy, P. D. Weinberg, G. Rimbach, and M. Marino
Daidzein-Sulfate Metabolites Affect Transcriptional and Antiproliferative Activities of Estrogen Receptor-{beta} in Cultured Human Cancer Cells
J. Nutr., November 1, 2005; 135(11): 2687 - 2693.
[Abstract] [Full Text] [PDF]

Home page
 Exp. Biol. Med.Home page
C. Atkinson, C. L. Frankenfeld, and J. W. Lampe
Gut Bacterial Metabolism of the Soy Isoflavone Daidzein: Exploring the Relevance to Human Health
Experimental Biology and Medicine, March 1, 2005; 230(3): 155 - 170.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.